Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
about
Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.The role and clinical implications of G6PI in experimental models of rheumatoid arthritisGene expression profiling in murine autoimmune arthritis during the initiation and progression of joint inflammation.Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of ArthritisProteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritisSuppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrowLocation of CD4+ T cell priming regulates the differentiation of Th1 and Th17 cells and their contribution to arthritis.CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis.Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis.Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.Attenuation of collagen-induced arthritis in mice by salmon proteoglycan.Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.Immune aging and rheumatoid arthritis.Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartmentPLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.Osteoarthritis-like damage of cartilage in the temporomandibular joints in mice with autoimmune inflammatory arthritisProteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparinIntramolecular polyspecificity in CD4 T-cell recognition of Ad-restricted epitopes of proteoglycan aggrecan.A longitudinal study on an autoimmune murine model of ankylosing spondylitis.Characterization of a novel and spontaneous mouse model of inflammatory arthritis.B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis.Various techniques for the evaluation of anti arthritic activity in animal modelsInterferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis.Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis.Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid ArthritisSuppression of dendritic cell maturation and T cell proliferation by synovial fluid myeloid cells from mice with autoimmune arthritis.Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID miceIn vivo two-photon imaging of T cell motility in joint-draining lymph nodes in a mouse model of rheumatoid arthritisNon-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models.Disease-promoting and -protective genomic loci on mouse chromosomes 3 and 19 control the incidence and severity of autoimmune arthritis.Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisB7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.Development of proteoglycan-induced arthritis is independent of IL-17.Genetics of rheumatoid arthritis - a comprehensive review.Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitorsSystemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis.Amplifying elements of arthritis and joint destruction.Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice
P2860
Q22000849-033C9F7B-6904-401A-8310-92989B4A0389Q24799403-C0C664BB-43DE-447A-A97D-9CAE6EC95163Q24803617-6ECFD184-956A-4628-8F44-DCACC8461843Q26768254-67D2C4B0-5F5E-4C5C-B456-B4ED481C8EF2Q27014005-DA8A69AA-743B-4115-B1A8-7A28F7CF3234Q28544715-A38F06D6-273E-4AE6-B23B-E0811285C10EQ30412824-69D27EBE-2044-4827-8297-545F6571D2B9Q30484967-63A9921B-4369-4E50-B8DF-59047BD8506EQ31076623-339A115D-7654-408F-A121-78B27C362EDBQ33399722-A6E141CA-EF82-4AF0-AA52-79209EE08270Q33488354-F8BBE524-8637-4ADE-B76E-104BE7E2A642Q33745638-D614E8E4-4262-4CCA-9EC1-4624AF834BFBQ33757939-86E8BD13-4593-4E72-87F6-5F4B13007B22Q34036703-EA929D77-E996-4F31-9260-AD49CD0629BCQ34039955-395EF7E5-EC3A-486A-BDF6-61195A9FE787Q34071603-2A26FE75-BC85-45C5-B41B-D4B2E3C9AB77Q34728844-C48331C1-724F-43F9-AFDB-972A4D8523B7Q34917019-A8F93577-F94A-4ECC-A3F1-729663410E15Q35067896-95D3EA66-9409-4290-95F1-61595F56FEFAQ35171396-BFA65BDB-DE33-45B4-A1A8-2AC3BBC984E1Q35555732-E697A9AD-3769-44A1-A18A-46B5A46846ECQ35617627-6E85EAAE-3A45-42CE-9F9C-4799F2DE1D50Q35623403-1D9D26AA-5507-4F37-BC86-48AD14FC4DE0Q35664708-A800FA95-A4C1-4159-BAE7-10E8D6B40C95Q35730023-5FB50052-ECB6-44B8-B770-8785C9F92E34Q36084943-121D8D4D-03D8-4444-8362-87FDEF833E43Q36088239-1D5EE2D4-BC2F-4C15-AC90-7228E6E19E31Q36109953-7A460456-A71C-4F20-807A-17EB92341ED0Q36123110-828CC448-5EAF-4DE4-8F65-740CE2B04D53Q36374046-0B424AC2-E502-4A69-86F7-A6A068031DD3Q36464468-59B8D286-1272-43A5-8664-B482F17D5B11Q36474444-4AA1CFAD-BF99-4B5E-834D-B0B193871391Q36673061-29388D2F-F81D-42FC-8C85-E6148AEAC71FQ36802430-7B3FAFF3-D27F-4D6C-87CD-E5400BCB2EBBQ36808811-1CE1BE93-C401-49B9-8131-8381B5955FDBQ36847390-61DC9DAB-E51B-45A8-8910-7838077D2C64Q36907665-F3C8C540-E925-465A-8BFD-4F2168765F36Q36953054-A55D071F-3E4A-4804-9CFD-D68036685454Q36969887-7283419B-2FBD-41F6-8168-23DB414CB004Q37173912-9FF52086-FD4A-4027-A6EE-7B4DC3C464A1
P2860
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@ast
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@en
type
label
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@ast
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@en
prefLabel
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@ast
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@en
P1476
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
@en
P2093
Alison Finnegan
Tibor T Glant
P304
P356
10.1615/CRITREVIMMUNOL.V23.I3.20
P577
2003-01-01T00:00:00Z